Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.16.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-4273.88South Korea
XBB.1.16.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.22.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.22.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FE.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FE.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBL.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBL.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.56NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.56NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.3.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.3.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.9.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.9.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FE.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FE.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.16.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.16.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FR.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FR.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.5.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.5.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FR.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FR.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.16.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.16.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.4.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.4.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FR.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FR.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FU.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FU.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.16.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.16.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBL.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBL.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.24.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.24.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.5.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.5.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HH.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used